Seek Labs

This report shows how we measure progress not by milestones alone, but by the standards we set for ourselves across impactful science, governance, and responsible business practices, outlining how we responsibly build our disease response platform powered by BioSeeker™.

Today, we’re proud to share our 2025 Innovation & Impact Report, a reflection of how we live our values while building science, systems, and culture in pursuit of one clear mission: positively impacting #GlobalHealth. Read the full report here: seeklabs.com/2025-innovatio…

And that’s a wrap on 2025! Last week, we celebrated an incredible year of innovation, collaboration, and milestones at Seek Labs. We’re especially grateful to every Seeker who helped make 2025 a standout year.

New from Seek Labs: our editorial review in @VirusesMDPI examines how AI, synthetic virology, and emerging pathogens are reshaping #biosecurity, and why future antivirals must be programmable and platform-based. Read more: seeklabs.com/ai-viruses-edi… #CRISPR #TechBio #AIDiscovery

This publication represents peer-reviewed validation of our programmable CRISPR-based therapeutic platform, reinforcing the potential of PTAP to transform disease response across animal and human health. Read more: seeklabs.com/peer-reviewed-…

Using our PTAP™ Platform, Seek Labs developed a #CRISPR-based therapeutic (SL_1.52) that achieved 57% survival, viral clearance in blood within 35 days, and lasting protective immunity in animals infected with a lethal #ASFV dose.

Seek Labs has published the first peer-reviewed study that demonstrates successful use of a CRISPR-based therapeutic to treat #AfricanSwineFever Virus (ASFV) in pigs. Read the full study in Viruses: mdpi.com/1999-4915/17/1… #CRISPR #ProgrammableTherapeutics #ASFV #AnimalHealth

Great to hear from our own Dr. Alison O’Mahony at the 2025 #UtahLifeSciencesSummit hosted by @BioUtah! She shared how Seek Labs is using AI through our #BioSeeker™ platform to accelerate discovery across therapeutics & diagnostics, advancing our mission to impact global health.

#WorldCRISPRDay reminds us how far biotech has come and how much potential lies ahead. Dr. Alison O’Mahony of Seek Labs discusses how CRISPR transformed biology into a programmable science—and how #PTAP and #BioSeeker are pushing it even further. seeklabs.com/world-crispr-d…

These mapped datasets now provide the foundation to design next-generation CRISPR-based therapeutics on Seek Labs’ Programmable Target Ablation Platform (PTAP™). Read the full announcement: seeklabs.com/hemorrhagic-fe… #PTAP #GlobalDiseaseAtlas #AIinBiotech #CRISPR

Today, Seek Labs announced a major expansion of the Global Disease Atlas™, powered by BioSeeker™, to include hemorrhagic fever viruses, which remain among the world’s most devastating #infectiousdiseases. #BioSeeker #GlobalHealthSecurity #Ebola #Marburg #Lassa #Hanta

This milestone represents more than progress; it’s proof of what can be possible when AI discovery meets programmable #CRISPR-based therapeutics. Read more: seeklabs.com/pan-orthopoxvi… #BioSeeker #PTAP #SeekLabs #Therapeutics

BioSeeker™ mapped more than 10,000 #orthopoxvirus isolates, identifying targetable regions that deliver 100% strain coverage across the viral family. Early in vitro testing of the BioSeeker-designed PTAP™ therapeutic construct achieved up to 90% viral KD in a vaccinia model.

Today, Seek Labs announced advanced development of a pan-#orthopoxvirus therapeutic, a breakthrough with critical implications for global health security. seeklabs.com/pan-orthopoxvi… #GlobalHealthSecurity #BiotechInnovation

Congratulations to our Vice President of Research, Dr. Anindita (Annie) Roy, who has been recognized by the Women Tech Council as a 2025 Women Tech Awards Rising Star in STEM. Read more: seeklabs.com/dr-roy-2025-wo… #WomenInSTEM #SeekLabs #Leadership #Biotech #GlobalHealth

Seek Labs brings forward our CRISPR-based therapeutics, POC molecular diagnostics, and AI-powered pathogen mapping to accelerate and help deliver rapid, scalable solutions to emerging health threats. Read more: seeklabs.com/arpa-h-and-rrp… #CRISPR #POCDx #BioSeeker #Biosecurity

We’re proud to announce Seek Labs has joined both the @ARPA_H Investor Catalyst Hub and @RRPV_Consortium, two national networks driving biomedical innovation & preparedness. Together, these memberships help us transform how the world responds to disease. #SeekLabs #ARPAH #BARDA

FMD joins other veterinary threats in the Global Disease Atlas. Now, we’re seeking collaborators across animal health, government, and pharma to advance the first programmable Tx candidate for FMD. Read the full press release here: seeklabs.com/foot-and-mouth… #BiotechInnovation

Today, Seek Labs announced the inclusion of Foot-and-Mouth Disease (FMD) in our BioSeeker™ Global Disease Atlas, expanding our mission to transform genomic data at scale into programmable, CRISPR-based therapeutics. #BioSeeker #PTAP #CRISPR

Safeguarding global food security requires tackling the diseases that destabilize livestock, trade, and economies. #AnimalHealth #GlobalHealth #FoodSecurity